The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Open in Twitter Parker Institute @parkerici What caught our eye at #AACR18? Find out in our first-ever list of #PICIPicks: https://t.co/6ZurKH1FO9 #immunotherapy #cancerresearch 2 days ago
Open in Twitter Parker Institute @parkerici RT @EJohnWherry: Nice study by Alex Huang presented at AACR. Neoadjuvant pembrolizumab appears effective for resectable melanoma https://t… 2 days ago